We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Blood transfusion

7 June 2010 By Robert Cyran

The private equity group is in line for more than a 20fold return on healthcare firm Talecris. Losses on disastrous investments in Chrysler and GMAC might have sent Cerberus to the underworld. Its nearly $2 bln profit on this one deal offers new life.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)